Mirena 20MCG/24HR 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTMG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,687
Award facts
- Contract value 100% obligated
- $13,687.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,687.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 20 mcg/24-hour contraceptive devices. The delivery order, issued on January 22, 2026, with an ultimate completion date of February 5, 2026, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded November 13, 2025, that authorizes DLA to procure a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally.
DMS Pharmaceutical Group has demonstrated substantial capability as a critical pharmaceutical supplier within the federal military medical supply chain, as evidenced by numerous delivery orders issued across multiple therapeutic categories since October 2025. The company's established performance history across diverse pharmaceutical product lines, ranging from specialty biologics and oncology treatments to routine medications and medical devices like the Mirena system, positions it as a key vendor for supporting recurring medical supply needs of military healthcare facilities worldwide. As a PPV-G GEN V prime vendor contractor operating under a 30-month base period with three 30-month option periods extending through December 31, 2036, DMS Pharmaceutical Group continues to serve as an essential component of the Defense Logistics Agency's broader pharmaceutical supply strategy.
Quick answers
Who was awarded contract SPE2DR26FBTMG?
SPE2DR26FBTMG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FBTMG worth?
The government has obligated $13,687 on SPE2DR26FBTMG.
Is contract SPE2DR26FBTMG an order under another contract?
Yes. SPE2DR26FBTMG is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTMG competed?
The extent of competition for SPE2DR26FBTMG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award